Connect Biopharma Holdings (CNTB) Current Leases (2020 - 2026)
Connect Biopharma Holdings (CNTB) posted Current Leases of $406000.0 for Q1 2026, up 26.09% sequentially from $322000.0 in Q4 2025, and down 54.89% YoY from $900000.0 in Q1 2025.
Connect Biopharma Holdings (CNTB) Current Leases (2020 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Current Leases for 7 years, with the latest figure at $406000.0 in Q1 2026.
- Quarterly Current Leases fell 54.89% year-over-year to $406000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $406000.0 (down 54.89% YoY) and the FY2025 annual result came in at $322000.0, up 109.09% from the prior year.
- Current Leases improved to $406000.0 in Q1 2026 per CNTB's latest filing, from $322000.0 in the prior quarter.
- Over five years, Current Leases peaked at $900000.0 in Q1 2025 and troughed at $154000.0 in Q4 2024.
- A 5-year average of $334994.7 and a median of $285000.0 in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2025 and 2026: Current Leases soared 109.09% in 2025, then tumbled 54.89% in 2026.
- Over 5 years, Current Leases stood at $181941.7 in 2022, then jumped by 56.64% to $285000.0 in 2023, then tumbled by 45.96% to $154000.0 in 2024, then jumped by 109.09% to $322000.0 in 2025, then rose by 26.09% to $406000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $406000.0, $322000.0, and $336000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 10 | Connect Biopharma Holdings | 143.37 Mn | 143.37 Mn | - | 393,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 393,000.00 |
| Mar 31, 2026 | 406,000.00 |
| Dec 31, 2025 | 322,000.00 |
| Sep 30, 2025 | 336,000.00 |
| Jun 30, 2025 | 350,000.00 |
| Mar 31, 2025 | 900,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Jun 30, 2024 | 252,000.00 |
| Dec 31, 2023 | 285,000.00 |
| Jun 30, 2023 | 272,000.00 |
| Dec 31, 2022 | 181,941.68 |
| Jun 30, 2022 | 226,000.00 |
| Dec 31, 2021 | 98,538.04 |
| Dec 31, 2020 | 91,139.55 |